CVS Stock Risk & Deep Value Analysis
CVS Health Corp
Healthcare • Healthcare Plans
DVR Score
out of 10
The Bottom Line on CVS
We analyzed CVS Health Corp using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran CVS through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.
CVS Stock Risk Analysis
Overall Risk
Moderate
Financial Risk
Medium
Market Risk
Medium
About CVS Health Corp (CVS)
Sector
Healthcare
Industry
Healthcare Plans
Market Cap Category
large
Market Cap
$100.39B
CVS Deep Value Analysis
Compare CVS to Similar Stocks
See how CVS Health Corp stacks up against related companies in our head-to-head analysis.
CVS Red Flags & Warning Signs
- âš
Unfavorable regulatory changes to PBM compensation or structure
- âš
Higher-than-expected integration costs or slower synergy realization from acquisitions
- âš
Increased competition from tech-enabled healthcare entrants or existing rivals
- âš
Economic downturn impacting consumer discretionary healthcare spending
Unlock CVS Red Flags & Risk Warnings
Create a free account to see the full analysis
CVS Financial Health Metrics
Market Cap
$100.39B
P/E Ratio
208.11
CVS Competitive Moat Analysis
Sign in to unlockMoat Rating
Wide
Moat Trend
Stable
Moat Sources
5 Identified
CVS's moat is durable, underpinned by its immense scale in retail pharmacy and PBM, the regulatory complexity of the healthcare sector (creating high barriers to entry), and the switching costs associated with its integrated Aetna and care service offerings. Its brand recognition is also a significant asset.
CVS Competitive Moat Analysis
Sign up to see competitive advantages
CVS Catalysts & Growth Drivers
Near-Term (0-6 months)
- •Q4 2025 Earnings Release (Estimated Early-February 2026)
- •Progress updates on Oak Street Health and Signify Health integration and synergy realization.
Medium-Term (6-18 months)
- •Expansion of value-based care models across more geographies/patient populations (6-18 months)
- •Resolution or clarity on PBM regulatory scrutiny reducing uncertainty (6-18 months)
Long-Term (18+ months)
- •Establishment of CVS as a leading integrated healthcare provider, driving significant cost efficiencies and improved patient outcomes (18+ months)
- •Continued shift towards personalized and preventative care, leveraged by CVS's extensive retail footprint (18+ months)
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
CVS Bull Case: What Could Go Right
- ✓
Acceleration in healthcare services revenue and margin expansion (particularly Oak Street Health)
- ✓
Consistent reduction in acquisition-related debt
- ✓
Favorable outcomes or clarity regarding PBM regulatory landscape
- ✓
Continued strong free cash flow generation and dividend growth
Bull Case Analysis
See what could go right with Premium
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.
